Search

AngelMD Closes Syndicate Funding Round in Fibralign

AngelMD,an investment and networking platform connecting innovative medical startups, physicians, investors, and industry partners, today announced that it has completed a Syndicate funding round for Fibralign, Inc. Fibralign produces therapeutic medical devices that target unmet needs in regenerative medicine using the company's patented Nanoweave® 3D scaffolding technology. The company's first product, BioBridge®, directly addresses an area of concern for cancer and cosmetic surgery patients who suffer from secondary lymphedema. The World Health Organization estimates that over 15 million people suffer from cancer-related lymphedema -- a disease which has no cure and causes long-term physi

WHO WE ARE

Fibralign Corporation is a developer of advanced therapeutic devices that utilizes Nanoweave ®, a proprietary scaffolding technology for addressing unmet medical needs.

Read More >

QUICK LINKS
GET IN TOUCH